Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Phase of Trial: Phase I
Latest Information Update: 28 Jan 2019
At a glance
- Drugs HSC-660 (Primary)
- Indications Alopecia
- Focus Adverse reactions
- Sponsors Histogen
- 28 Jan 2019 According to a Histogen media release, data are anticipated in 2019.
- 07 Sep 2018 Status changed from planning to recruiting.
- 27 Jul 2018 New trial record